Methyl 4-fluoro-2-hydroxy-3-nitrobenzoate, 97%, 1g

((3aR,4R,6R,6aR)-6-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2,2,3a-trimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol, 98%, 1g

ETHYL 3-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLATE, 95.0%, 250mg

Citric acid monohydrate, min. 99.5%, Ph.Eur., 2.5 kg, plastic packaging.

N-Carbobenzoxy-DL-norvaline>98.0%(T)5g

Spoons ROTILABO® multi-purpose spoon Small form, 150 mm, 1 Piece

tert-Butyl 4-(4-nitrobenzoyl)piperazine-1-carboxylate, 95.0%, 1g

C-[4-(4-Methoxy-phenyl)-tetrahydro-pyran-4-yl]-methylamine, 95.0%, 250mg

tert-Butyl (1S,2R,4S,5R)-7-oxo-3-oxa-6-azatricyclo[3.2.1.02,4]octane-6-carboxylate, 95%, 100mg

Cobalt ICP standard solution, ROTI®Star, 10000 mg/l Co, density (D) 1 g/cm³

N-Ethoxycarbonyl-5-nitro-o-toluidine>96.0%(GC)25g

2-Bromoimidazo[2,1-b][1,3,4]thiadiazole, 95.0%, 5g

2-{2-chloro-4-methanesulfonyl-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}-3-hydroxycyclohex-2-en-1-one, 97%, 100mg